Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer.

Karabulut M, Alis H, Bas K, Karabulut S, Afsar CU, Oguz H, Gunaldi M, Akarsu C, Kones O, Aykan NF.

Mol Clin Oncol. 2015 Nov;3(6):1255-1267. Epub 2015 Aug 31.

2.

A non-tight junction function of claudin-7-Interaction with integrin signaling in suppressing lung cancer cell proliferation and detachment.

Lu Z, Kim DH, Fan J, Lu Q, Verbanac K, Ding L, Renegar R, Chen YH.

Mol Cancer. 2015 Jun 17;14:120. doi: 10.1186/s12943-015-0387-0.

3.

Expression analysis of the estrogen receptor target genes in renal cell carcinoma.

Liu Z, Lu Y, He Z, Chen L, Lu Y.

Mol Med Rep. 2015 Jan;11(1):75-82. doi: 10.3892/mmr.2014.2766. Epub 2014 Oct 24.

4.

Claudin and ovarian cancer.

Bose CK, Mukhopadhyay A.

J Turk Ger Gynecol Assoc. 2010 Mar 1;11(1):48-54. eCollection 2010. Review.

5.

Emerging roles of claudins in human cancer.

Kwon MJ.

Int J Mol Sci. 2013 Sep 4;14(9):18148-80. doi: 10.3390/ijms140918148. Review.

6.

Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.

Lin X, Shang X, Manorek G, Howell SB.

PLoS One. 2013 Jun 21;8(6):e67496. doi: 10.1371/journal.pone.0067496. Print 2013.

7.

Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.

English DP, Santin AD.

Int J Mol Sci. 2013 May 17;14(5):10412-37. doi: 10.3390/ijms140510412. Review.

8.

Reduced expression of claudin-7 is associated with poor outcome in non-small cell lung cancer.

Yamamoto T, Oshima T, Yoshihara K, Yamanaka S, Nishii T, Arai H, Inui K, Kaneko T, Nozawa A, Woo T, Rino Y, Masuda M, Imada T.

Oncol Lett. 2010 May;1(3):501-505. Epub 2010 May 1.

9.

Epithelial-mesenchymal transition in ovarian carcinoma.

Davidson B, Tropé CG, Reich R.

Front Oncol. 2012 Apr 10;2:33. doi: 10.3389/fonc.2012.00033. eCollection 2012.

10.

Prognostic biomarkers in ovarian cancer.

Huang J, Hu W, Sood AK.

Cancer Biomark. 2010-2011;8(4-5):231-51. doi: 10.3233/CBM-2011-0212. Review.

11.

Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Dahiya N, Becker KG, Wood WH 3rd, Zhang Y, Morin PJ.

PLoS One. 2011;6(7):e22119. doi: 10.1371/journal.pone.0022119. Epub 2011 Jul 15.

12.

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.

Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK.

BMC Cancer. 2011 Feb 10;11:65. doi: 10.1186/1471-2407-11-65.

13.

A D-peptide analog of the second extracellular loop of claudin-3 and -4 leads to mislocalized claudin and cellular apoptosis in mammary epithelial cells.

Baumgartner HK, Beeman N, Hodges RS, Neville MC.

Chem Biol Drug Des. 2011 Feb;77(2):124-36. doi: 10.1111/j.1747-0285.2010.01061.x.

Items per page

Supplemental Content

Write to the Help Desk